All News about Alvotech - Ordinary Shares
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
From Alvotech
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://g.foolcdn.com/editorial/images/712319/pharmaceutical-factory-worker.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
February 27, 2023
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Settlement of Alvotech Private Share Placement Completed
February 10, 2023
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
January 24, 2023
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Completes $137 Million Private Share Placement
January 23, 2023
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://mms.businesswire.com/media/20230106005021/en/739014/5/teva_RGB_JPEG.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image20.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image30.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via Benzinga
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Completes $59.7 Million Private Placement
December 16, 2022
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
December 08, 2022
From Alvotech
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/12/07/image-prometheus_biosciences.png?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Secures Financing Facilities of Approximately $136 Million
November 16, 2022
From Alvotech
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022
From Alvotech
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9843.jpeg?width=1200&height=800&fit=crop)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
November 14, 2022
From Alvotech
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.